| Oct 30 2018 |
ONC and OCR Update HIPAA Security Risk Assessment Tool for National Cyber Security Awareness Month |
Jackson Lewis P.C. |
| Oct 29 2018 |
CMS Requests Comment on Potential International Pricing Index Model for Part B Drugs |
McDermott Will & Schulte LLP |
| Oct 29 2018 |
Part 1: CMS Proposed Rule on Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Program of All-inclusive Care for the Elderly (PACE), Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 29 2018 |
Trump Administration Proposes to Lower Drug Prices Through Medicare Part B |
Mintz |
| Oct 29 2018 |
Is Your e-PHI Secure? ONC and OCR Update HIPAA Security Risk Assessment Tool |
Jackson Lewis P.C. |
| Oct 29 2018 |
CMS Rolls Out Revised Local Coverage Determination Process |
Covington & Burling LLP |
| Oct 29 2018 |
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model |
Epstein Becker & Green, P.C. |
| Oct 29 2018 |
Congress’ Extensive Opioid Legislation Becomes Law |
Squire Patton Boggs (US) LLP |
| Oct 26 2018 |
How Broad is the Managed Care Safe Harbor? |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 26 2018 |
OIG Publishes Study on Claim and Payment Denials by Medicare Advantage Organizations |
Mintz |
| Oct 26 2018 |
McDermott's Plus Check-up: October 26, 2018 |
McDermott Will & Schulte LLP |
| Oct 26 2018 |
Final Comments Received Regarding FDA’s Nutrition Innovation Strategy |
Keller and Heckman LLP |
| Oct 26 2018 |
Portuguese Hospital Receives and Contests 400,000 € Fine for GDPR Infringement |
Covington & Burling LLP |
| Oct 25 2018 |
Top Five Takeaways from MedPAC’s Meeting on Medicare Issues and Policy Developments – October 2018 |
Epstein Becker & Green, P.C. |
| Oct 25 2018 |
Eleventh Circuit Rules Qui Tam Relator Barred from Forfeiture Case |
McDermott Will & Schulte LLP |
| Oct 25 2018 |
“Blocking Patent” Deterrence Effect May Discount Secondary Considerations for Follow-On Patents |
McDermott Will & Schulte LLP |
| Oct 25 2018 |
SUPPORT Act Expands Telehealth Treatment for Substance Use Disorders |
Dinsmore & Shohl LLP |
| Oct 25 2018 |
Six Things to Know About the New Section 1332 Waiver Guidance |
Mintz |
| Oct 25 2018 |
Strategies to Unlock AI's Potential in Health Care, Part 3: HIPAA and Other Privacy Considerations |
Mintz |
| Oct 25 2018 |
New Jersey Paid Sick Leave Law Update: NJDOL Issues New Guidance |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 25 2018 |
New Handbook Provides Guidance to Healthcare Delivery Organizations on Preparation and Response to Medical Device Cybersecurity Incidents |
Faegre Drinker |
| Oct 25 2018 |
OFCCP Updates in the Fall 2018 Regulatory Agenda |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Oct 25 2018 |
The Feds and New York Allow Further Access to CBD and Medical Cannabis |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Oct 24 2018 |
New Guidance Creates a New Playing Field for HRAs |
Ballard Spahr LLP |
| Oct 24 2018 |
Fall 2018 HHS Agency Rule List & FDA Device Center Guidance Priorities |
Mintz |
| Oct 24 2018 |
Massachusetts HPC Health Care Cost Trends Hearing: Key Takeaways |
Mintz |
| Oct 24 2018 |
FTC Commissioner Chopra Calls for Greater (and More Expensive) Enforcement |
Epstein Becker & Green, P.C. |
| Oct 24 2018 |
FDA Emphasizes Continued Commitment to Develop a Strong Tobacco Product Application Review Process |
Keller and Heckman LLP |
| Oct 24 2018 |
EPA Posts Final Work Plan for Nanosilver Registration Review Process |
Bergeson & Campbell, P.C. |
| Oct 23 2018 |
WHAT SAY YOU, NEW YORK? Now That Federal Antitrust Regulators Have Approved CVS’s Proposed Acquisition of Aetna, Attention Turns to New York State |
Sheppard, Mullin, Richter & Hampton LLP |
| Oct 23 2018 |
FDA Issues Draft to Update Prior Final Guidance on Premarket Cybersecurity for Medical Devices |
Barnes & Thornburg LLP |
| Oct 23 2018 |
WV Opioid Reduction Act Imposes New Restrictions and Responsibilities on Prescribers |
Steptoe & Johnson PLLC |
| Oct 23 2018 |
Six Initiatives States May Pursue to Curb Drug Prices and the 340B Factor |
Mintz |
| Oct 23 2018 |
CMS Unveils Proposed Rule Regarding Direct-to-Consumer Television Advertisements for Prescription Drug and Biological Products |
Epstein Becker & Green, P.C. |
| Oct 23 2018 |
Economic Trends and Your Board [Podcast] |
McDermott Will & Schulte LLP |
